A variety of 3,5-diphenyl-6-(5-p-toly1-1,3,4 thiadiazol-2yl)-3,3a,5,6 tetrahydro-2H pyr-azolo3,4-dthiazole 6ag were synthesized by the reaction of chalcone derivatives of 1,3,4 thiadiazol-2-yl)-thiazolidin-4-one 5a-g with hydrazine hydrate. The chemical structures of these compounds were confirmed by IR, NMR ( 1 H & 13 C) and mass spectral studies. Synthesized compounds 6a-g were evaluated for their antimicrobial and anti-tubercular activities. Some of the compounds exhibited well antimicrobial and anti-tubercular activities compared to the standard drugs.
Introduction
Because the resistance of pathogenic bacteria towards available antibiotics is rapidly becoming a major worldwide problem; the design of new class of chemical moieties to deal with resistance bacteria has become one of the important areas of antibacterial research today. In addition, fungal infections continue to increase rapidly because of the increased number of immuno compromised patients. As known, not only biochemical similarity of the human cell and fungi forms a handicap for selective activity, but also the easily gained resistance is the main problem noticed in developing safe and efficient antifungals. On the other hand, Mycobacterium tuberculosis re-mains a leading infectious and most dangerous cause of death in the world today. So, it is necessary to design a new kind of antimicrobial and anti tubercular agents.
Thiazoles are familiar class of heterocyclic moieties possessing a wide variety of biological activities and their utility as medicine is very much-established (Liaras et al., 2011) . Several physiological activities of thiazole derivatives have proved the efficiency in combating various diseases and noticed to have good antimicrobial activities (Vicini et al., 2006) . Among the important heterocycles, thiadiazoles are one of the privileged structural fragments in medicinal chemistry due to various biological activities, such as anti cancer (Matysiak et al., 2007) , anti tubercular (Solak et al., 2006; Foroumadi et al., 2002) , antibacterial (Thomasco et al., 2003; Kadi et al., 2007; Faroumadi et al., 2005a,b) , antidepressants (Varvaresou et al., 1998; Yusuf et al.,2008) , leishmanicidal (Faroumadi et al., 2005a,b) and anti-inflammatory agents (Schenone et al., 2006) . On the other hand pyrazoles are an important class of heterocycles and earlier workers have been synthesized and reported various pyrazole derivatives as antifungal (Prakash et al., 2008) , antiviral (Genin et al., 2000) , anti proliferative (Schenone et al., 2004) , antimicrobial (Tanitame et al., 2005; Tandon et al., 2005; Kane et al., 2003; Kucukgezel et al., 2000) , anti parasitic (Kuettel et al., 2007) and anti neoplastic agents (Farag et al. 2008; Diana et al., 2007) .
In view of the above mentioned facts it was contemplated to design and synthesize some 3,5-diphenyl-6-(5-p-tolyl-1,3, 4thiadiazol-2-yl)-3,3a,5,6-tetrahydro-2H pyrazolo3,4-dthiazole derivatives and evaluate their antimicrobial and anti-tubercular activities.
Experimental

Chemistry
All melting points were measured on open capillary method. IR spectra were recorded for KBr disc on a Schimadzu-8400 FTIR spectrophotometer. 1 H NMR, 13 C NMR spectra were measured on a Bruker Avance II 400 spectrometer, operating at 400, 100.6 MHz, respectively. Chemical shifts (d) are reported in parts per million and TMS as an internal standard. Molecular weights were determined with TOF MS ES Mass spectra. Reactions were monitored by thin layer chromatography (TLC) on silica gel, plates were visualized with ultraviolet light or iodine. Column chromatography was performed on silica gel 60 (0.043-0.06 mm) Merck.
2.1.1. General procedure for the synthesis of p-methyl benzoyl thiosemicarbazide: 1 A mixture of ethyl-p-methyl benzoate (0.01 mol) and thiosemicarbazide (0.01 mol) in methanol (25 ml) was refluxed for 10 h. The solvent was removed under reduced pressure and the viscous mass poured over ice water, filtered and recrystallized from methanol-water to afford compound 1. 2.1.2. General procedure for the synthesis of 5-p-Tolyl-1,3,4thiadiazol-2-yl amine 2 A mixture of compound 1 (0.05 mol) and conc. H 2 SO 4 (20 ml) was kept overnight at room temperature, then poured into cold water, neutralized with liquid ammonia and filtered. The product thus obtained was recrystallized from ethanolwater. m.p. 135°C, yield 61%; IR (KBr) m in cm À1 3350 (NH 2 ); 3058 (C-H in aromatic), 2968.63 (CH 3 ); 1598 (C‚N), 1221 (C-N), 1045 (N-N), 732.27 (C-S-C); 1 H NMR (400 MHz, CDCl 3 ) d in ppm; 7.62-7.35 (m, 4H, Ar-H), 6.35 (bs, 2H, NH 2 exchangeable with D 2 O), 3.01 (s, 3H, CH 3 ).
2.1.3. General procedure for the synthesis of Benzylidene-(5-ptolyl-1,3,4thiadiazol-2-yl)-amine 3 A mixture of 2 (0.01 mol) and benzaldehyde (0.01 mol) was refluxed in ethanol for 5 h with a few drops of glacial acetic acid. The solid separated on cooling was filtered, dried and recrystallized from benzene as needle shaped crystals were obtained.
Yield 73.2%, m.p.162-64°C; IR (KBr) m in cm À1 : 3032.2 (Ar-H), 2946.76 (C-H in CH 3 ), 1040.6 (N-N), 1608.61 (C‚N cyclic), 1221 (C-N), 683.7 (C-S); 1 H NMR (400 MHz, DMSO-d 6 ) d: 6.79-7.21 (m, 9H, Ar-H), 7.9 (s, 1H, N‚CH), 2.96 (s, 3H,CH 3 ).
2.1.4. General procedure for the synthesis of 2-Phenyl-3-(5-ptolyl-1,3,4thiadiazol-2-yl)-thiazolidin-4-one.4 A mixture of compound 3 (0.01 mol) and mercapto acetic acid (0.01 mol) in 1,4-dioxane (30 ml) containing a pinch of ZnCl 2 was refluxed for 8 h. The hot solution was filtered and cooled in an ice bath. The solid obtained was filtered, washed with 10% NaHCO 3 solution and was recrystallized from alcohol. Yield 70.9%, m.p. 181-184°C; IR (KBr) m in cm À1 : 2946.73 (C-H in CH 3 ), 2918.69 (C-H in CH 2 ), 1665 (C‚O), 1608.61 (C‚N), 1045.1 (N-N), 691.6 (C-S), 1 H NMR (400 MHz, DMSO-d 6 ) d: 6.91-7.8 (m, 9H, Ar-H), 5.13 (s, 1H, N-CH-Ar), 4.25 (s, 2H, SCH 2 C‚O), 2.91 (s, 3H, CH 3 ).
2.1.5. General procedure for the synthesis of 5-(4-Chlorobenzylidene)-2-phenyl-3-(5-p-tolyl-1,3,4thiadiazol-2-yl)thiazolidin-4-one.5a A mixture of compound 4 (0.01 mol), 4-chloro benzaldehyde (0.01 mol) and anhydrous sodium acetate (0.005 mol) in anhydrous glacial acetic acid (50 ml), was refluxed for 3 h. The reaction mixture was concentrated and then poured into ice cold water, the solid thus separated was filtered, washed with water and recrystallized from glacial acetic acid to afford pure brown color solid. Yield Similarly other compounds 5b-g were also synthesized and their characteristic analytical data are given below. 2.1.6. General procedure for the synthesis of 3-(4-Chlorophenyl)-5-phenyl-6-(5-p-tolyl-1,3,4thiadiazol-2-yl)-3,3a,5,6tetrahydro-2H-pyrazolo-3,4-dthiazole 6a A mixture of compound 5a (0.01 mol), hydrazine hydrate (0.01 mol) and anhydrous sodium acetate (0.005 mol) in anhydrous glacial acetic acid (50 ml), was refluxed for 8 h. The reaction mixture was concentrated and then poured into ice cold water. The solid thus separated was filtered, washed with water and recrystallized from ethanol to afford pure compound 6a; Other compounds 6b-g were also synthesized in the similar manner using compounds 5b-g. Characterization data are given below.
2.1.6.1.
3-(4-Nitro-phenyl)-5-phenyl-6-(5-p-tolyl-1,3,4thiadiazol-2-yl)-3,3a,5,6-tetrahydro-2H-pyrazolo-3,4-dthiazole 6b. 3, 136.1, 129.8, 127.6, 121.5, 115.9 (aromatics), 155.1, 153 .6 (C in thiadiazole ring), 68.9 (N-CH-Ar), 55.2 (OCH 3 ), 53.2 (CH), 52.01 (CH-N), 28.6 (CH 3 ). MS: m/z 486.39 (M+1, 30.1), 485.44 (M + , 28.9), 91 (100).
2.1. 3, 4, 3a, 5, IR (KBr) 
Pharmacology
Antimicrobial activity
The newly prepared compounds 6a-g were screened for their antimicrobial activity. This activity was determined by disc diffusion method. In this work Bacillus subtilis, Bacillus thuringiensis, Escherichia coli and Pseudomonas aeruginosa bacterial strains were used, and Candida albicans, Botrytis fabae and Fusarium oxysporum fungal strains were used. The compounds were dissolved in DMSO at a concentration of 1 mgml À1 . The antibacterial activity of each compound was compared with the standard drug Streptomycin and antifungal activity with Treflucan.
Anti tuberculosis activity
All the synthesized compounds of series (6a-g) were evaluated for their anti tubercular activity. Drug susceptibility and deter-mination of MIC of the test compounds against M. tuberculosis H37Rv were performed by agar micro dilution method, where two fold dilutions of each test compound were added into 7H10 agars supplemented with OADC and organism. A culture of used microorganism M. tuberculosis H37Rv growing on L-J medium was harvested in 0.85% saline with 0.05% Tween-80. A suspension of compounds was prepared in DMSO. This suspension was added to (in tubes) 7H10 middle brook's medium (containing 1.7 ml medium and 0.2 ml OADC supplement) at different concentrations of compound keeping the volume constant, that is, 0.1 ml medium was allowed to cool keeping the tubes in slanting position. These tubes were then incubated at 37°C for 24 h followed by streaking of M. tuberculosis H37Rv (5 · 104 bacilli per tube). These tubes were then incubated at 37°C. Growth of bacilli was seen after 30 days of incubation. The concentration at which complete inhibition of colonies occurred was taken as active concentration of test compound. Isoniazid was used as standard drug. The MIC levels of some active compounds (6a-g) against these organisms were given in Table 2 .
Results and discussion
Chemistry
The key intermediate, 4 required for the synthesis of title compounds was prepared according to the procedure outlined in Scheme 1. Condensation of ethyl p-methyl benzoate with thiosemicarbazide yielded the compound 1. This compound was dehydrated with conc. H 2 SO 4 to give compound (5-p-Tolyl- 1,3,4thiadiazol-2-yl amine) 2. Compound 2 was further reacted with benzaldehyde to give (Benzylidene-(5-p-tolyl-1,3,4thiadiazol-2-yl)-amine) 3. This was then reacted with mercapto acetic acid in the presence of anhydrous ZnCl 2 under conventional heating conditions to give compound 4 (Scheme 1). Compound 4 was then reacted with various aromatic aldehydes in the presence of anhydrous NaOAc in glacial AcOH at reflux temperature to give chalcone derivatives of thiazolidinones 5a-g. Compounds 5a-g on cyclo condensation with hydrazine hydrate in the presence of anhydrous NaOAc in glacial AcOH at reflux temperature gave 3-(substituted-phenyl)-5-phenyl-6-(5-p-tolyl-1,3,4thiadiazol-2-yl)-3,3a,5,6-tetrahydro-2H-pyrazolo-3,4-dthiazole derivatives 6a-g in good to excellent yields (Scheme 1). Their IR, 1 H NMR, 13 C NMR and MS analyses confirmed the structures of the synthesized compounds. In the present work, a series of new compounds were synthesized, Scheme 1 illustrate the path used for the preparation of target compounds. As starting materials, ethyl p-methyl benzoate and thiosemicarbazide were used to prepare thiazolo-pyrazole derivatives. The structures of the compounds were elucidated by IR, 1 H NMR, 13 C NMR and MS analyses. In the IR spectra of compounds 6a-g disappearance of amide carbonyl (C‚O) absorption band at $1683 cm À1 , which was present in compounds 5a-g, confirmed the cyclization or involvement of a, b -unsaturated carbonyl system. The C‚N, N-H bands of the pyrazole moiety were observed at about 1580 and 3265 cm À1 , respectively.
In the 1 H NMR spectra of compounds 6a-g recorded in DMSO-d 6 , the signal due to N-H protons appeared at 8.01-8.10 ppm as a singlet, the N-CH-Ar proton of thiazole ring at 5.2 ppm as a singlet, S-CH fused proton at 4.11-4.49 ppm as a doublet and N-CH fused proton at 4.53-4.91 ppm as a doublet.
These signals demonstrate that the cyclization step had occurred. All the other aromatic protons of 6a-g were observed at the expected regions.
In the 13 C NMR spectrum of compounds 6a-g recovered in DMSO-d 6 . The prominent signals corresponding to the carbons of thiazolo-pyrazole ring in all compounds observed nearly at 67.3, 80.2 and 158.1 ppm, are proof of further evidence of their structures. Mass spectra of all the synthesized compounds showed M + /M+1 peak, in agreement with their molecular formulae.
Antimicrobial activity
The results depicted in Table 1 revealed that most of the tested compounds displayed variable inhibitory effects on the growth of the tested Gram positive and Gram negative bacterial strains, and also against fungal strains.
The antibacterial screening data showed moderate activity of the test compounds, among the screened 6a, 6b and 6g in which thiazolo-pyrazole moiety bearing p-chlorophenyl, p-nitrophenyl and p-bromophenyl nucleus respectively show high activity against all the microorganisms employed. The activities of these compounds were almost equal to the standard. The remaining compounds showed moderate to good antibacterial activity.
On the other hand the antifungal screening data showed moderate activity of test compounds, among the screened 6a, 6e and 6f in which thiazolo-pyrazole moiety bearing p-chloro phenyl, p-methoxy phenyl and 3,4,5-trimethoxy phenyl nucleus respectively showed high degree of activity against all the micro organisms employed. The activities of these compounds were almost equal to the standard. The remaining compounds also showed moderate to good anti fungal activity.
Anti tuberculosis activity
The results depicted in Table 2 revealed that most of the tested compounds displayed variable inhibitory effects on the growth of the tested M. tuberculosis H37Rv strains.
Generally compounds possessing mesomerically electron withdrawing and inductively electron donating groups showed good anti-tubercular activity. Some derivatives (6a, 6b and 6g) containing electron-withdrawing groups (-Cl, -NO 2 , -Br) have shown promising activity against M. tuberculosis H37Rv.
Conclusion
In the present paper our aim has been verified by the synthesis of 5-(substituted-benzylidene)-2-phenyl-3-(5-p-tolyl-1,3,4thiadiazol-2-yl)-thiazolidin-4-one (5a-g) and 3-(substituted-phenyl)-5-phenyl-6-(5-p-tolyl-1,3,4thiadiazol-2-yl)-3,3a,5,6-tetrahydro-2H-pyrazolo-3,4-dthiazole (6a-g) derivatives, in which thiadiazole moiety is incorporated with thiazolo-pyrazole moiety in the same molecular framework. The obtained results revealed that most of the tested compounds (6a-g) show moderate anti bacterial, antifungal and anti tuberculosis activities comparable with standard commercial drugs and therefore become lead molecules for further synthetic and biological evaluation. Finally it can be concluded that this class of molecules certainly holds great promise towards the pursuit to discover novel class of antibacterial, antifungal and anti tuberculosis agents.
